Michael Keeney London, Canada Presence of NRBC’s predict for poor outcome in many disease states: Hemoglobinopathies Critical care MPD’S, Myelofibrosis Indication of fetal distress in newborn Detection of NRBCs was monitored daily in 383 medical intensive care patients. The incidence of NRBCs in medical intensive care patients was 17.5% (67/383). Mortality of NRBC-positive patients was 50.7% (34/67) the mortality of NRBC-negative patients was 9.8% (31/316) (p < 0.001) Mortality increased with increasing NRBC concentration. 78.6% of patients with NRBCs of more than 200/μl died. Nucleated red blood cells in the blood of medical intensive care patients indicate increased mortality risk: a prospective cohort study Axel Stachon Prematurity Increased erythropoiesis from chronic hypoxia, anaemia Maternal diabetes Acute stress mediated release from the marrow stores postnatal hypoxia Extreme increases may occasionally be idiopathic. Nucleated red blood cells in the fetus and Newborn. M C Hermansen pH 7.40–7.49 7.30–7.39 7.20–7.29 7.10–7.19 7.00–7.09 <7.00 Results are mean (1 SD). nRBCs/mm 630 (870) 840 (1630) 1240 (2090) 2330 (5130) 3040 (2060) 7780 (13 810) Nucleated red blood cells in the fetus and Newborn. M C Hermansen Manual count on Wrights/Giemsa stain. Two technologist count 200 cell differential and enumerate nucleated RBC as a non-totalling cell (excluded from differential) Express as number per 100 WBC e.g. 200 WBC, 4 NRBC 2 NRBC/100 WBC Observed WBC × (100 / (100 + NRBC*)) *NRBC ; The count as the number of NRBC pert 100 WBC. WBC count correction is not necessary when less than 5 (10) NRBC/100 WBC are present Depends on artefactual differences in distribution due to the process of spreading as well as random distribution Mean coefficient of variation for manual NRBC40% In a study addressing the performance of the manual differential, qualified medical technologists did not identify NRBC in 19% of samples Labour intensive, time-consuming, subjective and imprecise due to small number of NRBC counted Tsuji, Sakata, Hamaguchi,Wang and HouwenCytometry 37:291-301 1999 reagent lyses the RBC and enucleates, shrinks and slightly stains the nuclei of NRBC. WBC become permeable maintain shape, intracytoplasmic organelles and nuclei stain intensely with a polymethine-based dye staining intensities between NRBC nuclei and WBCs coupled with differing volumes detected by a laser using forward-scattered light and fluorescence intensities. argon laser in combination with two fluorescence channels to measure NRBC. reagent lyses the membrane of NRBC and mature erythrocytes,while WBC are left intact. propidium iodide binds to the nuclear DNA of the NRBCand WBC. combination of cell size and fluorescence intensity permits the separation of NRBC from the leucocyte population. NRBC enumeration is achieved by the identification of particles in the NRBC signature position in the differential DataPlot. This information is generated from VCS analysis of the cells In addition the far left region the WBC histogram is examined for the presence of cells. If cells are present in both locations then the NRBC count is derived from the WBC histogram, and NRBCs are reported. No NRBC’s in WBC histogram NRBC signature position No NRBC count and no WBC correction NRBC location on WBC histogram (Service Mode) NRBC signature position NRBC enumerated WBC correction Red Blood Cell Diagnostic Testing Using Flow Cytometry; Draft Guideline—Second Edition H52-A2 (Draft 1) Vol. 0 No. 0 Replaces H52-A Vol. 21 No. 26 25 uL whole blood 10 uL CD45 FITC Incubate 15 minutes at room temperature, protected from the light Add 250 uL Solution A (hypotonic acid with 100 mg/L PI) incubate exactly 30 seconds Add 500 uL Solution B (hypertonic alkaline) Incubate 5 minutes Keep samples on ice prior to analysis Tsuji, Sakata, Hamaguchi,Wang and Houwen Cytometry 37:291-301 1999 Region A =PI+ CD45- (NRBC) Region B = PI-/+ CD45+ (WBC) NRBC PER 100 WBC = A/B*100 Flow 3/100 wbc Manual 4/100 Flow 7/100 wbc Manual 4/100 Flow 300/100 wbc Manual 277/100 Comparison of The DxH 800 to reference flow Cytometry methods for platelets, wbc and NRBC’s B. D. HEDLEY, M. KEENEY, I. CHIN-YEE, W. BROWN Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56 45 NRBC counts for all samples collected (n = 201) on the DxH 800 vs. flow cytometry (FCM). R2 value for DxH 800 vs. FCM was 0.910. Receiver Operator Curves for DxH 800 vs. FCM: Sensitivity for DxH 800 vs. FCM was 73% Specificity for DxH 800 vs. FCM was 100%. LH 780 FP rate 3% FN rate 10% Sensitivity 56% Specificity 96% Bias 0.29 DxH 800 0% 6% 73% 100% 0.60 Absence of specific marker for NRBC Absence of CD45 on subset of B-cell precursor leukemia, childhood T-cell leukemia and in subsets of myeloma Lyse resistant RBCs (sickle cells, burr cells) Clumped platelets Sensitivity not validated below 1 NRBC/100 WBC Flow cytometry provides a novel and reliable methodology to evaluate the accuracy of NRBC, a key hematological parameter Bruce H. Davis, MD Ross Brown, PhD Andrea J. Illingworth, MS, H(ASCP), CQYM May-Jean King, PhD Beth H. Shaz, MD Belinda Kumpel, PhD Emily Riehm Meier, MD, FAAP S. Gerald Sandler, MD, FACP, FCAP D. Robert Sutherland, MSc Brent Wood, MD PhD CLSI Staff Liaison- Jennifer K. Adams, MT(ASCP), MSHA PROCEDURE 1. Add 25 µL well-mixed whole blood to 10 µL CD45 FITC. Vortex to mix. 2. Incubate 15 minutes at room temperature, protected from the light. 3. Add 250 µL of Solution A (acid lysing reagent). Vortex well. Let stand for 30 seconds at room temperature. Lyses RBC, Stains NRBC and degenerating WBC) Timing critical 4. Add 500 µL of Solution B (alkaline reagent). Vortex to mix. 5. Incubate for 5 minutes at room temperature, protected from the light. 6. Following incubation, store samples in melting ice bath, protected from the light. Stable for at least 30 mins NOTE: It is imperative that the incubation times described are strictly adhered to. In particular, lysing for longer than 30 seconds will adversely effect the light scatter of the white blood cell population.